Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Conjugate Vaccine Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Product Type (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccine)
4.2.2. By Disease Indication (Pneumococcal, Influenza, Meningococcal, Typhoid)
4.2.3. By End-User (Hospitals & Clinics, Ambulatory care Centers, Others)
4.2.4. By Region
4.2.5. By Company (2022)
4.3. Market Map
4.3.1. By Product Type
4.3.2. By Disease Indication
4.3.3. By End-User
4.3.4. By Region
5. Asia Pacific Conjugate Vaccine Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type
5.2.2. By Disease Indication
5.2.3. By End-User
5.2.4. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Conjugate Vaccine Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Product Type
5.3.1.2.2. By Disease Indication
5.3.1.2.3. By End-User
5.3.2. India Conjugate Vaccine Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Product Type
5.3.2.2.2. By Disease Indication
5.3.2.2.3. By End-User
5.3.3. Australia Conjugate Vaccine Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Product Type
5.3.3.2.2. By Disease Indication
5.3.3.2.3. By End-User
5.3.4. Japan Conjugate Vaccine Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Product Type
5.3.4.2.2. By Disease Indication
5.3.4.2.3. By End-User
5.3.5. South Korea Conjugate Vaccine Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Product Type
5.3.5.2.2. By Disease Indication
5.3.5.2.3. By End-User
6. Europe Conjugate Vaccine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Disease Indication
6.2.3. By End-User
6.2.4. By Country
6.3. Europe: Country Analysis
6.3.1. France Conjugate Vaccine Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By Disease Indication
6.3.1.2.3. By End-User
6.3.2. Germany Conjugate Vaccine Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By Disease Indication
6.3.2.2.3. By End-User
6.3.3. Spain Conjugate Vaccine Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By Disease Indication
6.3.3.2.3. By End-User
6.3.4. Italy Conjugate Vaccine Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Product Type
6.3.4.2.2. By Disease Indication
6.3.4.2.3. By End-User
6.3.5. United Kingdom Conjugate Vaccine Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Product Type
6.3.5.2.2. By Disease Indication
6.3.5.2.3. By End-User
7. North America Conjugate Vaccine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Disease Indication
7.2.3. By End-User
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Conjugate Vaccine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Disease Indication
7.3.1.2.3. By End-User
7.3.2. Mexico Conjugate Vaccine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Disease Indication
7.3.2.2.3. By End-User
7.3.3. Canada Conjugate Vaccine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Disease Indication
7.3.3.2.3. By End-User
8. South America Conjugate Vaccine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Disease Indication
8.2.3. By End-User
8.2.4. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Conjugate Vaccine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Disease Indication
8.3.1.2.3. By End-User
8.3.2. Argentina Conjugate Vaccine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Disease Indication
8.3.2.2.3. By End-User
8.3.3. Colombia Conjugate Vaccine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Disease Indication
8.3.3.2.3. By End-User
9. Middle East and Africa Conjugate Vaccine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Disease Indication
9.2.3. By End-User
9.2.4. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Conjugate Vaccine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Disease Indication
9.3.1.2.3. By End-User
9.3.2. Saudi Arabia Conjugate Vaccine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Disease Indication
9.3.2.2.3. By End-User
9.3.3. UAE Conjugate Vaccine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Disease Indication
9.3.3.2.3. By End-User
9.3.4. Egypt Conjugate Vaccine Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product Type
9.3.4.2.2. By Disease Indication
9.3.4.2.3. By End-User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. Global Conjugate Vaccine Market: SWOT Analysis
13. Porter?s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product
14. Competitive Landscape
14.1. Sanofi S.A
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Current Capacity Analysis
14.1.5. Financials (In case of listed)
14.1.6. Recent Developments
14.1.7. SWOT Analysis
14.2. Pfizer Inc.
14.3. Merck & Co. Inc.
14.4. GlaxoSmithKline plc
14.5. Bharat Biotech International Limited
14.6. Serum Institute of India Pvt. Ltd
14.7. Biological E. Limited
14.8. Bavarian Nordic A/S
14.9. CSL Limited
14.10. Novartis AG
15. Strategic Recommendations
16. About Us & Disclaimer